1. Sister chromatid exchanges induced by cancer chemotherapeutic agents in vitro and in vivo: Consideration of the hazard of drugs as possible mutagens and carcinogens causing second malignancies;Abe;Cancer Treat. Rep.,1985
2. New approaches to mutagenicity studies in animals for carcinogenic and mutagenic agents. II. Clastogenic effects determined in transplacentally treated mouse embryos;Adler;Teratog. Carcinog. Mutagen.,1983
3. Bleomycin-resistant cells contain increased bleomycin hydrolase activities;Akiyama;Biochem. Biophys. Res. Commun.,1981
4. Pharmacokinetics of bleomycin in man;Alberts;Cancer Chemother. Pharmacol.,1979
5. X-inactivation causes differences in FRAXC∗ CQ22.1 expression: evidence from a twin study of common fragile sites;Austin;Am. J. Hum. Genet.,1989